Cost-effectiveness of posaconazole versusfluconazole or itraconazole in the prevention of invasive fungal infections among high-risk neutropenic patients in Spain-Reference-Cited by-同舟云学术

Cost-effectiveness of posaconazole versusfluconazole or itraconazole in the prevention of invasive fungal infections among high-risk neutropenic patients in Spain

Published:2012-04-03 Issue:1 Volume:12 Page:
ISSN:1471-2334
Container-title:BMC Infectious Diseases
language:en
Short-container-title:BMC Infect Dis

Author:

Grau Santiago,de la Cámara Rafael,Sabater Francisco J,Jarque Isidro,Carreras Enric,Casado Miguel A,Sanz Miguel A

Publisher

Springer Science and Business Media LLC

Subject

Infectious Diseases

Link

http://link.springer.com/article/10.1186/1471-2334-12-83/fulltext.html

Reference43 articles.

1. Ascioglu S, de Pauw BE, Meis JF: Prophylaxis and treatmentof fungal infections associated with haematological malignancies. Int J Antimicrob Agents. 2000, 15: 159-168. 10.1016/S0924-8579(00)00159-X.

2. Bow EJ, Laverdière M, Lussier N, Rotstein C, Cheang MS, Ioannou S: Antifungal prophylaxis for severely neutropenic chemotherapy recipients: a meta-analysis of randomized controlled clinical trials. Cancer. 2002, 94: 3230-3246. 10.1002/cncr.10610.

3. Robenshtok E, Gafter-Gvili A, Goldberg E, Weinberger M, Yeshurun M, Leibovici L, et al: Antifungal prophylaxis in cancer patients after chemotherapy or hematopoietic stem-cell transplantation: systematic review and meta-analysis. J Clin Oncol. 2007, 25: 5471-5489. 10.1200/JCO.2007.12.3851.

4. Maertens J, Buve K, Anaissie E: Broad-spectrum antifungal prophylaxis in patients with cancer at high risk for invasive mold infections: counterpoint. J Natl Compr Canc Netw. 2008, 6: 183-189.

5. Gudlaugsson O, Gillespie S, Lee K, Vande Berg J, Hu J, Messer S, et al: Attributable mortality of nosocomial candidemia, revisited. Clin Infect Dis. 2003, 37: 1172-1177. 10.1086/378745.

Cited by 16 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The cost–utility analysis of antifungal prophylaxis for invasive fungal infections in acute myeloid leukaemia patients receiving chemotherapy: a study from a middle-income country;Journal of Hospital Infection;2024-03

2. Septic Obturation of a Knee Endoprosthesis Caused by Aspergillus clavatus;Pathogens;2023-10-23

3. Cost-Effectiveness of Posaconazole vs. First-Generation Triazoles for the Prevention of Invasive Fungal Infections Among High-Risk Patients With Hematological Malignancies in China;Frontiers in Public Health;2022-05-17

4. Budget Impact of Microbial Cell-Free DNA Testing Using the Karius® Test as an Alternative to Invasive Procedures in Immunocompromised Patients with Suspected Invasive Fungal Infections;Applied Health Economics and Health Policy;2020-09-17

5. Pediatric acute myeloid leukemia: updates on biology, risk stratification, and therapy;Current Opinion in Pediatrics;2020-02